Managing Mounjaro Side Effects: What Actually Helps

Side effects are most common in the first days after a new or increased dose — for most people, they ease within one to two weeks as the body adjusts.
Nausea, loose stools, constipation, reflux and fatigue are the effects reported most often in clinical trials; serious reactions are uncommon but do occur.
In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but potentially serious risk with GLP-1 medicines, severe stomach pain that spreads to the back needs urgent medical review.
You can report any suspected side effect, or a suspect seller, directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Most Mounjaro side effects are gastrointestinal, they peak in the first week or two after starting or increasing your dose, and there are practical steps that make a real difference. Knowing how to manage Mounjaro side effects before they arrive puts you in a much stronger position than waiting to be caught off-guard. As a prescription-only medicine, tirzepatide is started and adjusted under clinical supervision — and that relationship matters when things feel rough. This guide covers what causes the most common side effects, what you can do about them day to day, and the clearer signs that need prompt medical attention.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Practical strategies for each stage of Mounjaro treatment

What you're weighing up: managing discomfort versus stopping too soon

The decision most people face isn't really 'should I take Mounjaro?', it's 'how do I get through the first few weeks without giving up?' That's the frame worth keeping in mind. The treatment starts at 2.5mg specifically because that first pen is about helping your system adjust, not about the therapeutic effect. The dose that eventually drives meaningful weight loss comes later, once your body has had time to settle. Stopping early because early-onset nausea felt intolerable is one of the most common things our prescribers talk people through, and very often, a few targeted adjustments make the difference between continuing and abandoning treatment that could genuinely help.

The NHS tirzepatide patient information page confirms that nausea, vomiting, diarrhoea, constipation, indigestion, burping, fatigue, dizziness, headache and injection-site reactions are the most frequently reported effects. Understanding the full side-effect profile of Mounjaro helps you spot which category your symptoms fall into, and whether they need managing or monitoring. The strategies below address each major category in turn.

Day-to-day steps that reduce nausea and gut symptoms

Eating patterns matter more on tirzepatide than most people expect. Because the medicine slows how quickly your stomach empties, a large meal lands differently than it did before. Smaller portions eaten more slowly, with pauses rather than rushing, reduce the backlog of food sitting in the stomach and the nausea that follows. High-fat meals, very rich dishes and carbonated drinks all amplify symptoms, worth noting as practical triggers rather than permanent food rules.

A question our prescribers hear most weeks: 'Is the nausea worse because I took it at the wrong time of day?' Timing does matter for some people. Taking your injection in the evening means nausea peaks overnight rather than mid-afternoon, though that isn't right for everyone. Staying well hydrated is a consistent piece of practical advice, sipping steadily across the day is easier on a slowing gut than large drinks in one go. If nausea is the main challenge early on, the page on managing nausea on Mounjaro goes into considerably more depth on positioning and timing adjustments.

Constipation at lower doses and loose stools at higher ones affect different people at different points. Adequate fibre and water are the foundations; if either symptom persists, it's worth raising with your prescribing team before it becomes a reason to pause treatment. Injection sites are worth rotating, abdomen, thigh and upper arm are all licensed sites, and using the same spot repeatedly increases the likelihood of localised soreness or skin changes. The Patient Information Leaflet in your pen pack covers rotation technique.

Anxiety, mood changes and symptoms people mention less often

Gastrointestinal symptoms tend to dominate side-effect conversations, but some people notice other changes, fatigue, dizziness, headaches, or a feeling of low mood or heightened anxiety, especially around dose-increase days. Dizziness can follow from not eating enough or from dehydration compounding the medicine's appetite-suppressing effect. Eating a little, even when appetite is low, matters for maintaining blood sugar stability and energy.

The relationship between GLP-1 medicines and mood is an active area of clinical interest. If you notice significant changes in your mood or mental state, that is worth flagging to your prescriber rather than managing alone. The page on Mounjaro and anxiety sets out what is currently understood about this. Separately, some people taking Mounjaro who use oral contraceptives need additional contraceptive cover, specifically in the first four weeks of treatment and for four weeks after each dose increase, because absorption of the pill may be reduced. NHS guidance advises adding a non-oral method such as condoms during those windows; discuss this with your GP or prescriber if it applies to you.

For a broader look at the range of effects that occur at different dose levels, the most common Mounjaro side effects by frequency gives a structured overview drawn from trial data.

When symptoms need medical attention, not just management

Most side effects respond well to the adjustments above and resolve as the dose stabilises. Some do not, and a few need prompt assessment rather than self-management. The MHRA's January 2026 Drug Safety Update, covering all GLP-1 receptor agonist medicines, identifies acute pancreatitis as an infrequent but serious risk, the key symptom to act on is severe, persistent stomach pain that radiates towards the back, with or without vomiting. Do not wait to see if it passes. Seek urgent medical help the same day.

Other symptoms that warrant a call to 111 or your GP rather than a watchful wait: signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing), gallbladder symptoms (sharp upper-right abdominal pain, particularly after eating), significant dehydration from prolonged vomiting or diarrhoea, and any sudden changes in vision. Thoughts of self-harm or a marked low in mood should prompt contact with your prescriber or GP without delay.

Reporting matters too. If you experience a side effect you did not expect, or if you suspect a product you've received is not genuine, the MHRA Yellow Card scheme allows patients and carers to report directly and helps regulators monitor safety signals in real time. You can also reach our clinical team at any point through our support line, seven days a week.

If you're weighing whether to continue, pause, or discuss a dose adjustment, the best route is always your prescriber. Our guides on managing Mounjaro side effects and on how to stop Mounjaro side effects from disrupting your routine can help you prepare for that conversation. Our team at nume, about us

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions